NCT06128421

Brief Summary

This study aims to investigate the safety and efficacy of individual nutrition support for treating hepatitis b virus(HBV) related acute-on-chronic liver failure patients at nutrition risk

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Nov 2023

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 6, 2023

Completed
7 days until next milestone

First Posted

Study publicly available on registry

November 13, 2023

Completed
10 days until next milestone

Study Start

First participant enrolled

November 23, 2023

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 30, 2024

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 31, 2024

Completed
Last Updated

January 25, 2024

Status Verified

January 1, 2024

Enrollment Period

5 months

First QC Date

November 6, 2023

Last Update Submit

January 24, 2024

Conditions

Outcome Measures

Primary Outcomes (2)

  • Transplant free survival at 30 days

    30 days

  • Transplant free survival at 90 days

    90 days

Secondary Outcomes (8)

  • L3-SMI as a marker of muscle mass

    30 days, 90days

  • Grip as markers of muscle strength

    30 days, 90days

  • Short Physical Performance Battery (SPPB) as markers of physical performance

    30 days, 90 days

  • Improvement in quality of life

    30 days, 90days

  • length of hospital stay

    days in the hospital within index hospitalisation and within the 30 days of follow up measured by patient interview and medical chart review

  • +3 more secondary outcomes

Study Arms (2)

Trail Group

EXPERIMENTAL

30 patients will receive dietary counseling and individual nutrition support treatment based on Oral nutrition supplements and supplemented by parenteral nutrition.

Dietary Supplement: Individual nutritional support

Control Group

NO INTERVENTION

30 patients will receive standard care food provided by the hospital kitchen according to their ability and desire, standard care food provided by the hospital kitchen.

Interventions

Nutritional products and route(oral, parenteral)is possible to reach goals

Trail Group

Eligibility Criteria

Age20 Years - 60 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Age from 20 to 60 years old;
  • Clinical diagnosis of chronic hepatitis b virus infection(positive hepatitis b surface antigen or positive hepatitis b virus DNA \>0.5 year
  • serum total bilirubin level ≥12 mg/dl
  • prothrombin time international ratio ≥1.5
  • NRS≥ 3points
  • COSSH-ACLF IIs \<8.4 points

You may not qualify if:

  • Other active liver disease;
  • Hepatocellular carcinoma or other malignancy, HIV, Chronic kidney disease(CKD), diabetes, thyroid disease, cardiopulmonary disease, neuromuscular diseases, serious psychiatric disease;
  • Acute cholecystitis, acute pancreatitis, biliary obstruction, short bowel syndrome, intestinal obstruction, inflammatory bowel disease;
  • Severe complications or other organ failure including sever infection, gastrointestinal bleeding, hepatic encephalopathy, hepatorenal syndrome, gastrointestinal failure(AGI III-IV);
  • Pregnancy, BMI\<18.5 or BMI ≥28,organ transplantation, bed-ridden;
  • Unable to ingest oral nutrition, contraindication against parenteral nutrition
  • Admitted with enteral or parenteral nutrition in the last week
  • expected hospital length of stay\<3 days,.expected residence in Guangdong Province length of live\< 90 days

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Third Affiliated Hospital of Sun Yat-sen University

Guangzhou, Guangdong, 510630, China

RECRUITING

Related Publications (1)

  • Li Z, Luo Q, Wang P, Wang L, Zheng X, Zhang Y, Xu W, Peng L. Efficacy and safety of individual nutrition support in patients with hepatitis B virus-related acute-on-chronic liver failure at nutrition risk: a study protocol for a randomised controlled clinical trial. BMJ Open. 2024 Dec 9;14(12):e088832. doi: 10.1136/bmjopen-2024-088832.

MeSH Terms

Conditions

MalnutritionHepatitis B, ChronicAcute-On-Chronic Liver Failure

Condition Hierarchy (Ancestors)

Nutrition DisordersNutritional and Metabolic DiseasesHepatitis BBlood-Borne InfectionsCommunicable DiseasesInfectionsHepadnaviridae InfectionsDNA Virus InfectionsVirus DiseasesHepatitis, Viral, HumanHepatitis, ChronicHepatitisLiver DiseasesDigestive System DiseasesChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and SymptomsLiver Failure, AcuteLiver FailureHepatic Insufficiency

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

November 6, 2023

First Posted

November 13, 2023

Study Start

November 23, 2023

Primary Completion

April 30, 2024

Study Completion

October 31, 2024

Last Updated

January 25, 2024

Record last verified: 2024-01

Data Sharing

IPD Sharing
Will not share

Locations